|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
Valuation Estimation |
EPS (Current/Estimated)
-3.07/-2.79
|
Enterprise Value
831.81K
|
Balance Sheet |
Book Value Per Share
-0.41
|
Cash Flow |
Cash Flow Yield
--
|
Income Statement |
Total Revenue
9.94M
|
Operating Revenue Per Share
0.33
|
Industry Comparison
|
||||||||||||||||
|

Industry overview quotes are at least 15 minutes delayed
Business Description
|
|||
Syros Pharmaceuticals Inc is a biopharmaceutical company committed to developing new standards of care for the frontline treatment of patients with hematologic malignancies. |